Progyny, Inc. (PGNY) stock
PGNYNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 19/306% above fair value
$36.16−0.55 (-1.50%)
Close on Nov 18, 2026Market cap $2.77BP/E 39.3Yield –
Progyny gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Progyny's gross profit for the twelve months ending Jun 30, 2026 was $322.09M, up 16.1% year over year. For fiscal 2025 it was $304.48M, up 20.2% from the year before. The highest annual figure on record is $304.48M in fiscal 2025.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $304.48M | +20.2% |
| FY2024 | Dec 31, 2024 | $253.36M | +6.1% |
| FY2023 | Dec 31, 2023 | $238.80M | +42.7% |
| FY2022 | Dec 31, 2022 | $167.33M | +49.2% |
| FY2021 | Dec 31, 2021 | $112.14M | +60.1% |
| FY2020 | Dec 31, 2020 | $70.06M | +54.0% |
| FY2019 | Dec 31, 2019 | $45.51M | +134.2% |
| FY2018 | Dec 31, 2018 | $19.43M | +162.6% |
| FY2017 | Dec 31, 2017 | $7.40M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $89.30M | +13.1% |
| Q1 FY2026 | Mar 31, 2026 | $83.07M | +9.6% |
| Q4 FY2025 | Dec 31, 2025 | $76.88M | +21.2% |
| Q3 FY2025 | Sep 30, 2025 | $72.84M | +22.9% |
| Q2 FY2025 | Jun 30, 2025 | $78.97M | +15.7% |
| Q1 FY2025 | Mar 31, 2025 | $75.80M | +21.5% |
| Q4 FY2024 | Dec 31, 2024 | $63.43M | +11.5% |
| Q3 FY2024 | Sep 30, 2024 | $59.24M | -5.4% |
| Q2 FY2024 | Jun 30, 2024 | $68.28M | +12.6% |
| Q1 FY2024 | Mar 31, 2024 | $62.41M | +6.4% |
| Q4 FY2023 | Dec 31, 2023 | $56.89M | +27.9% |
| Q3 FY2023 | Sep 30, 2023 | $62.62M | +36.2% |
| Q2 FY2023 | Jun 30, 2023 | $60.64M | +38.2% |
| Q1 FY2023 | Mar 31, 2023 | $58.64M | +78.0% |
| Q4 FY2022 | Dec 31, 2022 | $44.49M | +77.2% |
| Q3 FY2022 | Sep 30, 2022 | $46.00M | +61.4% |
| Q2 FY2022 | Jun 30, 2022 | $43.89M | +48.2% |
| Q1 FY2022 | Mar 31, 2022 | $32.95M | +14.0% |
| Q4 FY2021 | Dec 31, 2021 | $25.12M | +21.5% |
| Q3 FY2021 | Sep 30, 2021 | $28.49M | +36.7% |
| Q2 FY2021 | Jun 30, 2021 | $29.62M | +147.8% |
| Q1 FY2021 | Mar 31, 2021 | $28.91M | +74.1% |
| Q4 FY2020 | Dec 31, 2020 | $20.67M | +75.6% |
| Q3 FY2020 | Sep 30, 2020 | $20.84M | +69.1% |
| Q2 FY2020 | Jun 30, 2020 | $11.96M | +4.4% |
| Q1 FY2020 | Mar 31, 2020 | $16.60M | +66.6% |
| Q4 FY2019 | Dec 31, 2019 | $11.77M | +117.3% |
| Q3 FY2019 | Sep 30, 2019 | $12.32M | +144.1% |
| Q2 FY2019 | Jun 30, 2019 | $11.45M | +127.3% |
| Q1 FY2019 | Mar 31, 2019 | $9.96M | +153.3% |
| Q4 FY2018 | Dec 31, 2018 | $5.42M | – |
| Q3 FY2018 | Sep 30, 2018 | $5.05M | – |
| Q2 FY2018 | Jun 30, 2018 | $5.04M | – |
| Q1 FY2018 | Mar 31, 2018 | $3.93M | – |
See a number that looks wrong?